DAIM
Live / Registered — Registered (as of 22 Nov 2022)
What this means for you
Registered since 22 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90898772
- Registration number
- 6904558
- Mark type
- Stylized text
- Filed
- 24 Aug 2021
- Published for opposition
- 06 Sept 2022
- Registered
- 22 Nov 2022
- Attorney of record
- Joseph L. Morales
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; all of the aforesaid goods being for the diagnosis, treatment, management or prevention of Type 1 diabetes
- Class 010 — Medical apparatus: Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes, namely, monitoring glucose level; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes, namely, for diabetes testing; Diagnostic, examination, and monitoring equipment, namely, blood glucose monitor; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments for monitoring glucose levels; Medical diagnostic instruments for measuring glucose levels in blood; Medical testing instruments for recording blood glucose levels; all of the aforesaid goods being for use in the diagnosis, treatment, management or prevention of Type 1 diabetes
- Class 035 — Advertising and business services: Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases; all of the aforesaid services being provided in connection with the diagnosis, treatment, management or prevention of Type 1 diabetes
- Class 044 — Medical, beauty and agricultural services: Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services in the field of diabetes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic testing services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis; all of the aforesaid services relating to the diagnosis, treatment, management or prevention of Type 1 diabetes
Owner
- Daim Pharma Ltd, London, GB
- Daim Pharma Ltd, London, GB
- Daim Pharma Ltd, London, GB
Prosecution history
- 22 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 06 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Sept 2022 — PUBLISHED FOR OPPOSITION
- 17 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Aug 2022 — EXAMINER'S AMENDMENT ENTERED
- 01 Aug 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Aug 2022 — EXAMINERS AMENDMENT E-MAILED
- 01 Aug 2022 — EXAMINERS AMENDMENT -WRITTEN
- 20 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jul 2022 — ASSIGNED TO LIE
- 30 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED